XML 39 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover Page - USD ($)
12 Months Ended
Dec. 31, 2020
Feb. 24, 2021
Jun. 30, 2020
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2020    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Entity Registrant Name ZIOPHARM Oncology, Inc.    
Entity Central Index Key 0001107421    
Current Fiscal Year End Date --12-31    
Entity Filer Category Large Accelerated Filer    
Trading Symbol ZIOP    
Document Transition Report false    
Document Annual Report true    
Security Exchange Name NASDAQ    
Title of 12(b) Security Common Stock    
Entity File Number 001-33038    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One One First Avenue    
Entity Address, Address Line Two Parris Building 34, Navy Yard Plaza    
Entity Address, City or Town Boston    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02129    
Entity Tax Identification Number 84-1475642    
City Area Code 617    
Local Phone Number 259-1970    
Entity Well-known Seasoned Issuer Yes    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Interactive Data Current Yes    
Entity Shell Company false    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Common Stock, Shares Outstanding   214,667,023  
Entity Public Float     $ 687,342,598